IL17A and chronic obstructive pulmonary disease: On the other hand, the ability of anti-CD3/CD28-activated CD8+CD25+ T-cells from COPD patient group to express IFN-γ, IL-4 or IL-17A was preserved, with levels close to those observed in the control group (Fig. 1).